126 related articles for article (PubMed ID: 11053299)
1. Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic rats.
Mori F; King GL; Clermont AC; Bursell DK; Bursell SE
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3955-62. PubMed ID: 11053299
[TBL] [Abstract][Full Text] [Related]
2. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1.
Takagi C; Bursell SE; Lin YW; Takagi H; Duh E; Jiang Z; Clermont AC; King GL
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2504-18. PubMed ID: 8933767
[TBL] [Abstract][Full Text] [Related]
3. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
Bursell SE; Takagi C; Clermont AC; Takagi H; Mori F; Ishii H; King GL
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2711-20. PubMed ID: 9418723
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia.
Takagi C; King GL; Takagi H; Lin YW; Clermont AC; Bursell SE
Invest Ophthalmol Vis Sci; 1996 Sep; 37(10):2099-109. PubMed ID: 8814149
[TBL] [Abstract][Full Text] [Related]
5. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats.
Bursell SE; Clermont AC; Oren B; King GL
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):596-607. PubMed ID: 7890491
[TBL] [Abstract][Full Text] [Related]
6. Effects of nitric oxide synthase inhibition and endothelin ETA receptor blockade on haemodynamics in hypertensive rats.
Granstam SO; Lind L; Granstam E; Fellström B
Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):693-701. PubMed ID: 9750958
[TBL] [Abstract][Full Text] [Related]
7. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
[TBL] [Abstract][Full Text] [Related]
8. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H
Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 is elevated in monocrotaline pulmonary hypertension.
Frasch HF; Marshall C; Marshall BE
Am J Physiol; 1999 Feb; 276(2):L304-10. PubMed ID: 9950893
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide in regulation of retinal blood flow in response to hyperoxia in cats.
Izumi N; Nagaoka T; Sato E; Sogawa K; Kagokawa H; Takahashi A; Kawahara A; Yoshida A
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4595-603. PubMed ID: 18552394
[TBL] [Abstract][Full Text] [Related]
12. Contribution of endothelin to the coronary vasoconstriction in the isolated rat heart induced by nitric oxide synthase inhibition.
Wang QD; Gonon A; Shimizu M; Sjöquist PO; Pernow J
Acta Physiol Scand; 1998 Aug; 163(4):325-30. PubMed ID: 9789575
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy.
Clermont AC; Aiello LP; Mori F; Aiello LM; Bursell SE
Am J Ophthalmol; 1997 Oct; 124(4):433-46. PubMed ID: 9323935
[TBL] [Abstract][Full Text] [Related]
14. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo.
Cardillo C; Kilcoyne CM; Cannon RO; Panza JA
Hypertension; 2000 Jun; 35(6):1237-41. PubMed ID: 10856270
[TBL] [Abstract][Full Text] [Related]
15. Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps.
Clermont AC; Brittis M; Shiba T; McGovern T; King GL; Bursell SE
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):981-90. PubMed ID: 8125761
[TBL] [Abstract][Full Text] [Related]
16. Effects of endothelin receptor antagonists on renal hemodynamics in angiotensin II-infused rats on high NaCl intake.
Saeed A; Dibona GF; Guron G
Kidney Blood Press Res; 2012; 36(1):258-67. PubMed ID: 23171921
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of endothelin-induced rat pulmonary arterial dilatation.
Higashi T; Ishizaki T; Shigemori K; Yamamura T; Nakai T
Br J Pharmacol; 1997 Jun; 121(4):782-6. PubMed ID: 9208148
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-dependent changes in retinal blood flow following ischemia.
Gidday JM; Zhu Y
Curr Eye Res; 1998 Aug; 17(8):798-807. PubMed ID: 9723995
[TBL] [Abstract][Full Text] [Related]
19. ET(B) receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit.
Gratton JP; Cournoyer G; Löffler BM; Sirois P; D'Orléans-Juste P
Hypertension; 1997 Nov; 30(5):1204-9. PubMed ID: 9369277
[TBL] [Abstract][Full Text] [Related]
20. Different responses of arterioles and venules in rat gastric mucosal microcirculation to endothelin-1 and endothelin-3.
Ohno T; Katori M; Majima M; Hayashi H; Saigenji K
J Clin Gastroenterol; 1995; 21 Suppl 1():S56-S65. PubMed ID: 8774992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
